With online submissions open on the Australian Medical Research and Innovation Priorities 2018–2020 until 31 August 2018, interested parties are invited to comment.
Consistent with the Medical Research Future Fund Act 2015 (the Act), the independent Australian Medical Research Advisory Board (AMRAB) is conducting a national consultation to inform the development of the second set of Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities (Priorities) 2018-2020. The timeframe is to ensure the second set of Priorities takes effect from the day the inaugural MRFF Priorities expire, 8 November 2018.
MRFF Priorities serve to inform future Government decisions on MRFF initiatives and therefore it is important that the community is engaged in their development.
AMRAB is interested in hearing reflections on the first set of MRFF Priorities, the Australian Medical Research and Innovation Priorities 2016-2018, and how the next set of Priorities should extend or reset the direction of the MRFF. Those to be engaged include the Australian public, organisations with expertise in health and medical research and innovation, consumer representatives, clinicians and health services managers. The 2018-2020 Priorities need to be a robust articulation of areas of strategic research investment opportunity articulated by the community.
For more information about how to provide a written submission, see https://consultations.health.gov.au/health-economics-and-research-division/medical-research-future-fund-consultation-for-the/ AusBiotech members are invited to submit comment for consideration in its submission by 28 August 2018.